News

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.
The so-called 'King Kong' of weight-loss drugs can cause side effects like nausea, but may also help users build healthy ...
At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...
SPRINGFIELD, Mo. (KY3) - Should you try a GLP-1 weight loss drug or surgery? Dr. Tim Woods of CoxHealth shares advice for ...
Academics at King's College London and the University of East Anglia have released guidance for GPs on how to manage patients ...
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
As Wegovy ushers in a new wave of weight-loss drugs to tackle India's growing obesity crisis, Dr. Rishma Pai sheds light on their use in obese women dealing with PCOS, infertility, and menopausal ...